Concepedia

Mary Ann DeGroote

MA

Statistics

Publications

10

Citations

897

H-Index

10

Active since

1999

Affiliations

Colorado State University(Current)

University of Colorado Health

National Jewish Health

University of Colorado Denver

University of Colorado Anschutz Medical Campus

Mary Ann DeGroote is an author at Colorado State University specializing in pharmacology, tuberculosis pharmacotherapy, and life sciences.

Publications per year

1999–2018

10

Publications

10

Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection

Maurizio Renna, Catherine Schaffner, Karen Brown et al. · Journal of Clinical Investigation · 2011 · 308 citations · Full text

, , +17

Virulent <i>Salmonella typhimurium</i> has two periplasmic Cu, Zn-superoxide dismutases

Ferric C. Fang, Mary Ann DeGroote, John W. Foster et al. · Proceedings of the National Academy of Sciences · 1999 · 230 citations · Full text

, , +17

Preclinical testing of new drugs for tuberculosis: current challenges

Anne J. Lenaerts, Mary Ann DeGroote, Ian M. Orme · Trends in Microbiology · 2008 · 86 citations

, , +12

A metabolic biosignature of early response to anti-tuberculosis treatment

Sebabrata Mahapatra, Ann M. Hess, John L. Johnson et al. · BMC Infectious Diseases · 2014 · 72 citations · Full text

, , +16

Treatment of Non-Tuberculous Mycobacterial Lung Disease

Julie V. Philley, Mary Ann DeGroote, Jennifer R. Honda et al. · Current treatment options in infectious diseases/Current treatment options in infectious disease · 2016 · 58 citations

, , +12

1–5 of 10